U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07932925) titled 'The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight' on Oct. 27.
Brief Summary: The purpose of this study is to learn about the safety and effectiveness of berobenatide in adult women who have both stress urinary incontinence (SUI) and obesity or overweight.
Participants will be in the study for about 63 weeks
Study Start Date: Nov. 17
Study Type: INTERVENTIONAL
Condition:
Urinary Incontinence, Stress
Overweight and/or Obesity
Intervention:
DRUG: Berobenatide
Berobenatide administered by subcutaneous injection
DRUG: Placebo
Plac...